Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP was delisted on the 7th of March, 2019.
77 hedge funds and large institutions have $116M invested in Synergy Pharmaceuticals, Inc Common Stock in 2013 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 35 increasing their positions, 18 reducing their positions, and 6 closing their positions.
94% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 18
84% more call options, than puts
Call options by funds: $381K | Put options by funds: $207K
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
9% more capital invested
Capital invested by funds: $106M → $116M (+$9.5M)
7% more funds holding
Funds holding: 72 → 77 (+5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
+$2.84M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.87M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.32M |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
+$1.27M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BM
Bridger Management
New York
|
-$4.6M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$1.05M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$885K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$543K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$492K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AA
76
Apriem Advisors
Irvine,
California
| $1K | +$1.35K | +301 | New |
|
77
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $291 | -$15K | -3,338 | -5% |
|
|
BM
78
Bridger Management
New York
| – | -$4.6M | -1,079,251 | Closed |
|
|
DCM
79
Driehaus Capital Management
Chicago,
Illinois
| – | -$1.05M | -246,485 | Closed |
|
|
TC
80
TFS Capital
West Chester,
Pennsylvania
| – | -$885K | -207,680 | Closed |
|
|
MWNA
81
Marshall Wace North America
New York
| – | -$240K | -56,450 | Closed |
|
|
DTL
82
Dynamic Technology Lab
Singapore
| – | -$126K | -29,531 | Closed |
|
|
FCH
83
Freestone Capital Holdings
Seattle,
Washington
| – | -$77K | -18,116 | Closed |
|
SGYP Hedge Fund Activity: Q3 2013 in Review
77 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc Common Stock (SGYP) for Q3 2013, worth a combined $116M — up 9% from $106M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new SGYP positions and 6 closed out — a net gain of 5 holders — while 35 added to existing stakes and 18 trimmed.
The largest buyer was UBS AM, opening a new position worth an estimated $2.84M. The largest seller was Bridger Management, exiting entirely with an estimated $4.6M sold.
- 77 institutional investors held Synergy Pharmaceuticals, Inc Common Stock (SGYP) as of Q3 2013, up from 72 in Q2 2013.
- Funds reported $116M of Synergy Pharmaceuticals, Inc Common Stock stock for Q3 2013, up 9% quarter-over-quarter.
- 11 funds opened new Synergy Pharmaceuticals, Inc Common Stock positions in Q3 2013 and 6 closed out, a net change of +5 holders.
- The largest Synergy Pharmaceuticals, Inc Common Stock buyer in Q3 2013 was UBS AM, an estimated $2.84M added.
- The largest Synergy Pharmaceuticals, Inc Common Stock seller in Q3 2013 was Bridger Management, an estimated $4.6M sold.
Based on aggregated 13F filings for Q3 2013.